Citation Impact
Citing Papers
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
2005 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Management of Stroke in Infants and Children
2008
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
2015
Myasthenia Gravis
2016 Standout
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout
Rheumatoid arthritis
2016 Standout
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
2010 Standout
Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes
2009
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA)
2008
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
Interferon therapy in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis of the comparative trials
2010
Activation and regulation of the inflammasomes
2013 Standout
Tight junction proteins expression and modulation in immune cells and multiple sclerosis
2011
Type I IFN Promotes IL-10 Production from T Cells to Suppress Th17 Cells and Th17-Associated Autoimmune Inflammation
2011
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
2008 Standout
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
2011 Standout
Cognitive impairment in multiple sclerosis
2008 Standout
Identification of a Metabolizing Enzyme in Human Kidney by Proteomic Correlation Profiling
2013
Glial connexins and gap junctions in CNS inflammation and disease
2008
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
IL-6 as a keystone cytokine in health and disease
2015 Standout
Multiple sclerosis
2008 Standout
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
2014 Standout
N-Acetyl-L-Aspartate in Multiple Sclerosis
2006
Sensors of the innate immune system: their link to rheumatic diseases
2010 StandoutNobel
Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis
2011
Immunopathology of multiple sclerosis
2015 Standout
Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis
2010 Standout
N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology
2007 Standout
Design of the Efficacy of Prednisone in the Treatment of Ocular Myasthenia (EPITOME) trial
2012
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Sex differences in autoimmune diseases
2011
A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody–associated vasculitis
2009
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
2017 StandoutNobel
Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial
2009
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis
2012
Defining Disease Activity and Response to Therapy in MS
2017
Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
2006
IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases
2016
IgG4-related disease
2014 Standout
Regulation of type I interferon responses
2013 Standout
New Multiple Sclerosis Phenotypic Classification
2014 Standout
Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
2020 StandoutNobel
B cells as therapeutic targets in autoimmune neurological disorders
2008
Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme
2009 Standout
Sex differences in immune responses
2016 Standout
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration
2010
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ
2014 Standout
Non-diffeomorphic registration of brain tumor images by simulating tissue loss and tumor growth
2009
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Identification and development of new therapeutics for multiple sclerosis
2008
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
2009
B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation
2015
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Myasthenia gravis: subgroup classification and therapeutic strategies
2015 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
What Are the Key Arguments Against Uric Acid as a True Risk Factor for Hypertension?
2013
Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets
2015
Assessing disability progression with the Multiple Sclerosis Functional Composite
2009
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
2014
Can retinal imaging accurately detect optic neuritis?
2010
The Role of Glycogen Synthase Kinase 3 in Regulating IFN-β–Mediated IL-10 Production
2010
Multiple Sclerosis
2018 Standout
Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial
2015
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2010 Standout
Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier
2015
Mammalian Sirtuins: Biological Insights and Disease Relevance
2010 Standout
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Atacicept: targeting B cells in multiple sclerosis
2010
A review of the current use of rituximab in autoimmune diseases
2008
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
2012
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Interferon-β Therapy Against EAE Is Effective Only When Development of the Disease Depends on the NLRP3 Inflammasome
2012
Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis
2018 StandoutNobel
Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy
2015
Physiology of Microglia
2011 Standout
SIRT1 Activation Confers Neuroprotection in Experimental Optic Neuritis
2007
Works of Clyde Markowitz being referenced
The Treatment of Multiple Sclerosis with Inosine
2009
Macular Volume Determined by Optical Coherence Tomography as a Measure of Neuronal Loss in Multiple Sclerosis
2009
US FDA-Approved Disease-Modifying Treatments for Multiple Sclerosis
2005
Relation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
2006
Immunomodulatory Agents for the Treatment of Relapsing Multiple Sclerosis
2002
Treatment of Susac syndrome with gamma globulin and corticosteroids
2006
Relapsing-remitting Multiple Sclerosis and Whole-BrainN-Acetylaspartate Measurement: Evidence for Different Clinical Cohorts—Initial Observations
2002
Validation and Test Characteristics of a 10-Item Neuro-Ophthalmic Supplement to the NEI-VFQ-25
2006
Retinal Imaging by Laser Polarimetry and Optical Coherence Tomography Evidence of Axonal Degeneration in Multiple Sclerosis
2008
Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial
2008
Relation of vision to global and regional brain MRI in multiple sclerosis
2007
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite
2003
The current landscape and unmet needs in multiple sclerosis.
2010
Multiparametric tissue abnormality characterization using manifold regularization
2008
Interferon-beta
2007